Autor: |
Profita M; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy. Electronic address: profita@ibim.cnr.it., Riccobono L; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Montalbano AM; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Bonanno A; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Ferraro M; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Albano GD; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Gerbino S; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy., Casarosa P; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Pieper MP; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Gjomarkaj M; Institute of Biomedicine and Molecular Immunology 'A. Monroy' (IBIM), Italian National Research Council (CNR), Palermo, Italy. |